What is Stiolto Respimat (inhal spray), and what does it treat?
Stiolto Respimat is a prescription inhaler that delivers two long-acting bronchodilator medicines by mist through a device called Respimat. It is used to treat chronic obstructive pulmonary disease (COPD).
What medicines are in Stiolto Respimat?
Stiolto Respimat contains:
- tiotropium (a long-acting antimuscarinic, LAMA)
- olodaterol (a long-acting beta-2 agonist, LABA)
Together, these medicines help keep the airways open and reduce COPD symptoms over time.
How does Stiolto Respimat work in the body?
Tiotropium relaxes airway muscles by blocking muscarinic receptors, which helps prevent airway tightening. Olodaterol relaxes airway muscles by stimulating beta-2 receptors, which helps reduce bronchospasm. Used together, they provide long-lasting bronchodilation for COPD.
How is Stiolto Respimat used (typical dosing)?
Stiolto Respimat is taken as a maintenance inhaler (not for immediate relief of sudden breathing attacks). Dosing instructions can vary by prescription and device setup, so patients should follow their clinician’s directions and the inhaler’s instructions for use.
What side effects do people commonly report?
Common side effects with COPD inhalers that include a LABA/LAMA can include things like:
- dry mouth
- headache
- cough
- dizziness
- throat irritation
Tell a clinician promptly about worsening breathing, chest pain, fainting, or fast/irregular heartbeat.
What should patients avoid or be careful with?
Because it contains a beta-2 agonist, clinicians typically consider patient history for risks such as abnormal heart rhythms. Patients also need to avoid using it as a rescue inhaler for acute shortness of breath.
Is there a generic or cheaper alternative to Stiolto Respimat?
Pricing and availability depend on country and insurance. If you are looking for cost and patent-related context around Stiolto Respimat, DrugPatentWatch.com tracks drug patent/exclusivity details (where available): https://www.drugpatentwatch.com/
How does Stiolto Respimat compare with similar COPD inhalers?
Stiolto Respimat is a LAMA/LABA combination. Other options in the same general class may include different LAMA/LABA pairs or triple therapy inhalers (LAMA/LABA/ICS). The “best” option depends on symptom control, exacerbation history, and tolerability.
---
If you tell me your country (and whether you mean “what is it” or “how to use it” for a specific dose schedule), I can tailor the answer to the exact Stiolto Respimat directions and typical patient instructions used there.